Your browser doesn't support javascript.
loading
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda, Tatsuki; Kumagai, Ayako; Iriguchi, Shoichi; Yasui, Yutaka; Miyasaka, Tadayo; Nakagoshi, Kengo; Nakane, Kazuki; Saito, Keigo; Takahashi, Mari; Sasaki, Aki; Yoshida, Shinsuke; Takasu, Naoko; Seno, Hiroshi; Uemura, Yasushi; Tamada, Koji; Nakatsura, Tetsuya; Kaneko, Shin.
Affiliation
  • Ueda T; Shin Kaneko Laboratory, Department of Cell growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Kumagai A; Shin Kaneko Laboratory, Department of Cell growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Iriguchi S; Shin Kaneko Laboratory, Department of Cell growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Yasui Y; Shin Kaneko Laboratory, Department of Cell growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Miyasaka T; Thyas Co. Ltd, Kyoto, Japan.
  • Nakagoshi K; Shin Kaneko Laboratory, Department of Cell growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Nakane K; Shin Kaneko Laboratory, Department of Cell growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Saito K; Shin Kaneko Laboratory, Department of Cell growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Takahashi M; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Sasaki A; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Yoshida S; Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Takasu N; Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Seno H; Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Uemura Y; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Tamada K; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Nakatsura T; Department of Immunology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Kaneko S; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
Cancer Sci ; 111(5): 1478-1490, 2020 May.
Article in En | MEDLINE | ID: mdl-32133731
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Lymphocytes / Glypicans / Induced Pluripotent Stem Cells / Receptors, Chimeric Antigen Type of study: Guideline Limits: Animals / Female / Humans Language: En Journal: Cancer Sci Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Lymphocytes / Glypicans / Induced Pluripotent Stem Cells / Receptors, Chimeric Antigen Type of study: Guideline Limits: Animals / Female / Humans Language: En Journal: Cancer Sci Year: 2020 Document type: Article